| [1] |
Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(10):589-604.
|
| [2] |
Li C, Li R, Zhang W. Progress in non-invasive detection of liver fibrosis[J]. Cancer Biol Med, 2018, 15(2):124-136.
|
| [3] |
Forner A, Reig M, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2018, 391(10127):1301-1314.
|
| [4] |
Dawkins J, Webster RM. The hepatocellular carcinoma market[J]. Nat Rev Drug Discov, 2019, 18(1):13-14.
|
| [5] |
Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis[J]. Trends Biochem Sci, 2017, 42(4):297-311.
|
| [6] |
Hatakeyama S. TRIM proteins and cancer[J]. Nat Rev Cancer, 2011, 11(11):792-804.
|
| [7] |
Fujimura T, Inoue S, Urano T, et al. Increased expression of tripartite motif (TRIM) 47 is a negative prognostic predictor in human prostate cancer[J]. Clin Genitourin Cancer, 2016, 14(4):298-303.
|
| [8] |
Li W, Zhang W, Deng W, et al. Quantitative proteomic analysis of mitochondrial proteins differentially expressed between small cell lung cancer cells and normal human bronchial epithelial cells[J]. Thorac Cancer, 2018, 9(11):1366-1375.
|
| [9] |
Liang Q, Tang C, Tang M, et al. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4[J].J Exp Clin Cancer Res, 2019, 38(1):159.
|
| [10] |
Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017, 19(8):649-658.
|
| [11] |
Asplund A, Edqvist PH, Schwenk JM, et al. Antibodies for profiling the human proteome-the human protein Atlas as a resource for cancer research[J]. Proteomics, 2012, 12(13):2067-2077.
|
| [12] |
Hou GX, Liu P, Yang J, et al. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter[J]. PLoS One, 2017, 12(3):e0174515.
|
| [13] |
Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment[J]. Nat Med, 2014, 20(11):1242-1253.
|
| [14] |
Micale L, Chaignat E, Fusco C, et al. The tripartite motif: structure and function[J]. Adv Exp Med Biol, 2012(770):11-25.
|
| [15] |
Cambiaghi V, Giuliani V, Lombardi S, et al. TRIM proteins in cancer[J]. Adv Exp Med Biol, 2012(770):77-91.
|
| [16] |
Zhou Z, Liu Y, Ma M, et al. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway[J]. Biomed Pharmacother, 2017(96):98-103.
|
| [17] |
Huang XQ, Zhang XF, Xia JH, et al. Tripartite motif-containing3 (TRIM3) inhibits tumor growth and metastasis of liver cancer[J]. Chin J Cancer, 2017, 36(1):77.
|
| [18] |
Li L, Dong L, Qu X, et al. Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion[J]. Int J Oncol, 2016, 48(4): 1639-1649.
|
| [19] |
Han Y, Tian H, Chen P, et al. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma[J]. Oncotarget, 2017, 8(14):22730-22740.
|